INNT
TOTAL INVALIDATION PROCESSED BY THE IB
31/05/2025
Voltar para busca
Dado oficial do USPTO
ZENIT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
37
Atualização mais recente
01/06/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
9, 10
Data de depósito
07/06/2016
Data de registro
07/11/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/05/2024
Última transação
01/06/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
IT
Examinador
LAVACHE, LINDA
Unidade examinadora
L60
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the word "ZENIT" where all of the letters are grey, except for the letter "E", which is formed by three horizontal lines, where the top line is blue, the middle line is grey, and the bottom line is green. The middle line is shorter than the top and bottom lines.
Titulares e representantes
Titulares
A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.
Representantes
Matthew D. Asbell Ladas & Parry LLP
Classificação técnica
Classes Nice
Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Diagnostic apparatus for laboratory or research use for automatically reading and interpreting specimens by indirect immunofluorescence on cell substrates; diagnostic equipment for scientific or laboratory usefor detecting antibodies; diagnostic apparatus for the detection of antibodies for laboratory or scientific research use; diagnostic equipment for scientific or laboratory usemicroplate and glass slide processors; diagnostic equipment for scientific or laboratory usemicroplate readers; diagnostic equipment for scientific or laboratory useplatesglass slides and chips having multi-well arrays that can be used in chemical analysis and biological analysis for patterning; diagnostic apparatus for automatically reading and interpreting specimens by indirect immunofluorescence on cell substratesthe diagnostic apparatus having as an integral componentpreloaded software that enables image capture and storageimmunofluorescence detectionpattern recognitionautomated analysis; diagnostic equipment for scientific or laboratory use for detecting antibodiesthe diagnostic equipment having as an integral componentpreloaded software for automating enzyme linked immunosorbent assayimmunofluorescence assay and microarray methods; diagnostic apparatus for automatically reading and interpreting specimens by indirect immunofluorescence on cell substratesthe diagnostic apparatus having as an integral componentpreloaded software for the detection of antibodies for laboratory or research use; diagnostic equipment for scientific or laboratory usemicroplate processors and glass slide processorsthe diagnostic equipment having as an integral componentpreloaded software for automating enzyme linked immunosorbent assayimmunofluorescence assay and microarray methods
Classe 10
Medical apparatus for automatically diagnosingreading and interpreting specimens by indirect immunofluorescence on cell substrates; medical diagnostic apparatus for the detection of antibodies in autoimmune diseases; medical diagnostic instruments for the analysis of blood and body fluids; immunological analyzers for medical diagnostic purposes; medical apparatus for automatically diagnosingreading and interpreting specimens by indirect immunofluorescence on cell substratesthe medical apparatus having as an integral componentpreloaded software that enables image capture and storageimmunofluorescence detectionpattern recognitionautomated analysis; medical diagnostic apparatus for the detection of antibodies in autoimmune diseasesthe medical diagnostic apparatus having as an integral componentpreloaded software for the detection of antibodies in autoimmune diseases; medical diagnostic instruments for the analysis of blood and body fluidsthe medical diagnostic instruments having as an integral componentpreloaded software for the analysis of blood and body fluids; immunological analyzers for medical diagnostic purposesthe immunological analyzers having as an integral component preloaded software for detecting immune system components; hematology analyzers for medical diagnostic purposesthe hematology analyzers having as an integral component preloaded software for blood cell analysis
Publicações
Histórico de despachos e eventos da marca no USPTO.
37 publicações encontradas
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
29/03/2025
XXCR
GENERIC MADRID TRANSACTION CREATED
29/03/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
24/01/2025
C71T
CANCELLED SECTION 71
24/05/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/11/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
13/04/2018
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
14/02/2018
XXCR
GENERIC MADRID TRANSACTION CREATED
14/02/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/02/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
07/11/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22/08/2017
PUBO
PUBLISHED FOR OPPOSITION
22/08/2017
GPNX
NOTIFICATION PROCESSED BY IB
18/08/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/08/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/08/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/08/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/07/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
14/07/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
14/07/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
14/07/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
14/07/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/06/2017
CNFR
FINAL REFUSAL MAILED
03/05/2017
CNFR
FINAL REFUSAL WRITTEN
03/05/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/04/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/04/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/04/2017
RFNT
REFUSAL PROCESSED BY IB
25/11/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/11/2016
RFRR
REFUSAL PROCESSED BY MPU
09/11/2016
MAFR
APPLICATION FILING RECEIPT MAILED
18/10/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
16/10/2016
CNRT
NON-FINAL ACTION WRITTEN
15/10/2016
DOCK
ASSIGNED TO EXAMINER
12/10/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/10/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/10/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ZENIT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.